Linked Data API

Show Search Form

Search Results

1187901
star this property registered interest false more like this
star this property date less than 2020-03-25more like thismore than 2020-03-25
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care remove filter
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Coronavirus more like this
unstar this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government what steps they have taken to ascertain the source of COVID-19; what assessment they have made of the response by countries where the virus was initially detected; and what steps they intend to take to hold any government which withheld information about COVID-19 to account. more like this
star this property tabling member printed
Lord Blencathra more like this
star this property uin HL2915 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
unstar this property date of answer less than 2020-04-07more like thismore than 2020-04-07
unstar this property answer text <p>On 31 December 2019, the World Health Organization (WHO) was informed of a cluster of cases of pneumonia of unknown cause detected in Wuhan City, Hubei Province, China. On 12 January 2020 the WHO posted a Disease Outbreak News where it was announced that a novel coronavirus had been identified in samples obtained from cases. Initial analysis of virus genetic sequences suggested that this particular virus was the cause of the outbreak. This virus is referred to as SARS-CoV-2, and the associated disease as COVID-19.</p><p>Public Health England has been in regular contact with laboratories and public health organisations within Europe and South East Asia in order to understand the systems they have adopted in relation to contact tracing, risk assessments, guidance and laboratory processes. These knowledge exchanges led to the development of the antigen test used in the United Kingdom and shaped our approach to contact tracing and the risk assessments undertaken of aircraft and cruise ships.</p>
star this property answering member printed Lord Bethell more like this
star this property question first answered
less than 2020-04-07T11:38:24.317Zmore like thismore than 2020-04-07T11:38:24.317Z
star this property answering member
4708
star this property label Biography information for Lord Bethell more like this
star this property tabling member
497
unstar this property label Biography information for Lord Blencathra more like this
1187902
star this property registered interest false more like this
star this property date less than 2020-03-25more like thismore than 2020-03-25
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care remove filter
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Paracetamol more like this
unstar this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government what steps they are taking to produce paracetamol, and any ingredients required for its production, in the UK. more like this
star this property tabling member printed
Lord Blencathra more like this
star this property uin HL2916 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
unstar this property date of answer less than 2020-04-07more like thismore than 2020-04-07
unstar this property answer text <p>The United Kingdom already has just under 25% of paracetamol finished product sites, producing supplies for the UK, based in this country, and just under 20% of the manufacturing sites producing the active pharmaceutical ingredient required to make paracetamol.</p><p>We are aware that there has been a significant increase in paracetamol demand over the recent weeks. We are working with all suppliers of paracetamol to monitor and assess available supplies and demand, and to make additional stock available and prioritise further deliveries.</p> more like this
star this property answering member printed Lord Bethell more like this
star this property question first answered
less than 2020-04-07T11:35:40.717Zmore like thismore than 2020-04-07T11:35:40.717Z
star this property answering member
4708
star this property label Biography information for Lord Bethell more like this
star this property tabling member
497
unstar this property label Biography information for Lord Blencathra more like this
1187621
star this property registered interest false more like this
star this property date less than 2020-03-24more like thismore than 2020-03-24
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care remove filter
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Coronavirus: Airports more like this
unstar this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government what steps they are taking to conduct universal testing for COVID-19 at airports in England. more like this
star this property tabling member printed
Baroness Goudie more like this
star this property uin HL2859 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
unstar this property date of answer less than 2020-04-06more like thismore than 2020-04-06
unstar this property answer text <p>On 12 March 2020 the Prime Minister announced that the COVID-19 response was moving from the contain to delay phase. This phase has been initiated as there is now community transmission of the virus in the United Kingdom, i.e. transmission not directly related to travel; this has made interventions in ports of less relative importance. With the shift to the delay phase and commensurate policy changes, the Public Health England approach is that testing capacity should not be focused on airports.</p> more like this
star this property answering member printed Lord Bethell more like this
star this property question first answered
less than 2020-04-06T11:20:09.487Zmore like thismore than 2020-04-06T11:20:09.487Z
star this property answering member
4708
star this property label Biography information for Lord Bethell more like this
star this property tabling member
3575
unstar this property label Biography information for Baroness Goudie more like this
1187628
star this property registered interest false more like this
star this property date less than 2020-03-24more like thismore than 2020-03-24
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care remove filter
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Health Professions: Insurance more like this
unstar this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government whether legal costs related to any (1) inquest, (2) regulatory, (3) employment, and (4) criminal, proceedings against healthcare professionals, including pharmacists, resulting from an inadvertent error made in the workplace when dealing with the COVID-19 pandemic will be covered by their professional indemnity scheme. more like this
star this property tabling member printed
Lord Kennedy of Southwark more like this
star this property uin HL2866 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
unstar this property date of answer less than 2020-04-06more like thismore than 2020-04-06
unstar this property answer text <p>The Clinical Negligence Scheme for Trusts and the Clinical Negligence Scheme for General Practice, both administered by NHS Resolution, provide indemnity for clinical negligence liabilities for healthcare workers for the majority of NHS services in England. Some staff, such as community pharmacy professionals, are indemnified by their employer or hold their own personal indemnity product. Sections 10, 11 and 12 in the Coronavirus Act 2020 enables the Secretary of State to provide indemnity for clinical negligence liabilities arising from National Health Service activities carried out for the purposes of dealing with, or in consequence of, the coronavirus outbreak, where there is no existing indemnity arrangement in place. Together these schemes cover healthcare staff for clinical negligence liabilities arising during the COVID-19 pandemic. The new sections in the Act are effectively a backstop where other indemnity arrangements do not apply.</p><p> </p><p>NHS Resolution also meets legal representation costs at some inquests, on a discretionary basis, under the Clinical Negligence Scheme for Trusts. The state schemes do not extend to the costs of legal representation at regulatory, employment or criminal proceedings and many healthcare professionals obtain their own cover for these contingencies.</p><p> </p><p>We also recognise the importance for healthcare professionals of access to medico-legal advice and support, and the Medical Defence Organisations and other indemnity providers and are providing this advice and support to healthcare professionals assisting with the COVID-19 response.</p>
star this property answering member printed Lord Bethell more like this
star this property question first answered
less than 2020-04-06T11:33:49.663Zmore like thismore than 2020-04-06T11:33:49.663Z
star this property answering member
4708
star this property label Biography information for Lord Bethell more like this
star this property tabling member
4153
unstar this property label Biography information for Lord Kennedy of Southwark more like this
1187636
star this property registered interest false more like this
star this property date less than 2020-03-24more like thismore than 2020-03-24
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care remove filter
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Coronavirus: Disease Control more like this
unstar this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government what assessment they have made of advances made by open sourcing research in relation to testing vaccines and treatments for COVID-19; what steps they have taken to ensure cooperation with scientific and research institutions in real time; with which countries such cooperation occurs; and in particular, whether they cooperate with such institutions in (1) South Korea, (2) Israel, (3) China, and (4) other G20 members. more like this
star this property tabling member printed
Lord Mann more like this
star this property uin HL2874 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
unstar this property date of answer less than 2020-04-07more like thismore than 2020-04-07
unstar this property answer text <p>Public Health England and other United Kingdom scientists and clinicians are members of several World Health Organization (WHO) working groups that cover new therapeutics, vaccines, diagnostics and sero-epidemiology. There is excellent collaboration across many countries, including those in the G20.</p><p>Data and presentations have been shared at these working groups by many countries including China, South Korea, Hong Kong, Australia, the Netherlands, France, Canada, the UK and the United States of America. There are publicly available outputs from these groups on the WHO Blueprint Research and Development website, one of which is the draft landscape of COVID-19 candidate vaccines.</p> more like this
star this property answering member printed Lord Bethell more like this
star this property question first answered
less than 2020-04-07T11:42:00.397Zmore like thismore than 2020-04-07T11:42:00.397Z
star this property answering member
4708
star this property label Biography information for Lord Bethell more like this
star this property tabling member
1387
unstar this property label Biography information for Lord Mann more like this
1187637
star this property registered interest false more like this
star this property date less than 2020-03-24more like thismore than 2020-03-24
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care remove filter
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Coronavirus: Salbutamol more like this
unstar this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government what plans they have to increase the availability of Ventolin; and what consideration they have given to enabling patients with symptoms of COVID-19 to purchase Ventolin without a prescription. more like this
star this property tabling member printed
Lord Mann more like this
star this property uin HL2875 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
unstar this property date of answer less than 2020-04-06more like thismore than 2020-04-06
unstar this property answer text <p>The Department has no current plans to enable salbutamol (for example, Ventolin by GSK) to be purchased over the counter without a prescription. The sale, supply and administration of prescription-only medicines, like Ventolin, are restricted by the Human Medicines Regulations 2012 which are designed to protect the public. The main route by which a pharmacist is able to sell or supply a prescription-only medicine is under the authority of a prescription.</p><p> </p><p>The country is well prepared to deal with the impacts of COVID-19 and we have stockpiles of certain medicines, including salbutamol, in the event of any supply issues or significant increases in demand.</p><p> </p> more like this
star this property answering member printed Lord Bethell more like this
star this property question first answered
less than 2020-04-06T11:36:55.687Zmore like thismore than 2020-04-06T11:36:55.687Z
star this property answering member
4708
star this property label Biography information for Lord Bethell more like this
star this property tabling member
1387
unstar this property label Biography information for Lord Mann more like this
1187652
star this property registered interest false more like this
star this property date less than 2020-03-24more like thismore than 2020-03-24
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care remove filter
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading NHS: Identity Cards more like this
unstar this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government what steps they are taking, if any, to protect NHS staff following reports of staff being mugged for their NHS staff identification cards. more like this
star this property tabling member printed
Lord Taylor of Warwick more like this
star this property uin HL2890 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
unstar this property date of answer less than 2020-04-06more like thismore than 2020-04-06
unstar this property answer text <p>The Government condemns any instance of violence, abuse or robbery of National Health Service staff – such behaviour is despicable. Any robbery or attempted robbery of a NHS staff ID card should be reported to the police immediately, as it is a criminal offence.</p><p>The NHS and the Crown Prosecution Service recently signed the Joint Agreement on Offences Against Emergency Workers. This agreement sets out a framework for the effective investigation and prosecution of cases where emergency workers are the victim of a crime and the standards that victims of these crimes can expect. The definition of an emergency worker in this agreement also includes all those who are employed to support the provision of NHS health services.</p><p>NHS organisations will also have local arrangements in place to support staff who are the victim of a crime.</p> more like this
star this property answering member printed Lord Bethell more like this
star this property question first answered
less than 2020-04-06T11:40:07.48Zmore like thismore than 2020-04-06T11:40:07.48Z
star this property answering member
4708
star this property label Biography information for Lord Bethell more like this
star this property tabling member
1796
unstar this property label Biography information for Lord Taylor of Warwick more like this
1187330
star this property registered interest false more like this
star this property date less than 2020-03-23more like thismore than 2020-03-23
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care remove filter
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading In Vitro Fertilisation more like this
unstar this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government, further to the Written Answers by Baroness Blackwood of North Oxford on 20 January (HL277) and Lord Bethell on 5 March (HL1701) and 18 March (HL2406), what outcomes the Human Fertilisation and Embryology Authority consider to be adverse following mitochondrial donation treatment; whether such outcomes include (1) implantation failure, (2) spontaneous miscarriage, and (3) the termination of a pregnancy following the detection of unanticipated abnormalities; and what assessment they have made of the reason for the lack of live births pursuant to the application of such treatments. more like this
star this property tabling member printed
Lord Alton of Liverpool more like this
star this property uin HL2792 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
unstar this property date of answer less than 2020-04-02more like thismore than 2020-04-02
unstar this property answer text <p>The Human Fertilisation and Embryology Authority (HFEA) have advised that this information is set out in its Code of Practice at section 33.35, which states:</p><p>“If a centre becomes aware that a child born following mitochondrial donation has been born with a mitochondrial disease, birth defect, or genetic abnormality, or if there has been some other adverse outcome (including but not limited to failed or no embryo development, miscarriage or premature birth) following treatment involving mitochondrial donation, the centre must regard this as an adverse incident and report this to the HFEA in line with the requirements on adverse incidents set out in guidance note 27. This is to capture information about any abnormalities that may occur as a result of carrying out the MST (maternal spindle transfer) or PNT (pro-nuclear transfer) treatment, to inform any regulatory or licensing action that the HFEA may wish to take and to inform the scientific sector.”</p><p>The HFEA has made no assessment of the efficacy of mitochondrial treatment to date as the number of treatments is so low, at this stage.</p>
star this property answering member printed Lord Bethell more like this
star this property question first answered
less than 2020-04-02T15:22:58.887Zmore like thismore than 2020-04-02T15:22:58.887Z
star this property answering member
4708
star this property label Biography information for Lord Bethell more like this
star this property tabling member
738
unstar this property label Biography information for Lord Alton of Liverpool more like this
1187332
star this property registered interest false more like this
star this property date less than 2020-03-23more like thismore than 2020-03-23
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care remove filter
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Coronavirus: Hydroxychloroquine more like this
unstar this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government what assessment they have made of reports about the success of using hydroxychloroquine to treat COVID-19, following a study carried out by Professor Raoult, director of the Institut Hospitalo-Universitaire de Marseille. more like this
star this property tabling member printed
Lord Alton of Liverpool more like this
star this property uin HL2794 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
unstar this property date of answer less than 2020-04-02more like thismore than 2020-04-02
unstar this property answer text <p>The Department is considering carefully all available evidence around the potential of different medicines for use in treating COVID-19. Clinical trials are ongoing and being developed to assess the benefits of a number of different medicines in treating COVID-19.</p><p>Hydroxychloroquine is not currently licensed to treat COVID-19 related symptoms or prevent infection. Clinical trials are being established to test hydroxychloroquine as an agent in the treatment of COVID-19. These clinical trials are still not completed, so no conclusions have yet been reached on the safety and effectiveness of this medicine to treat or prevent COVID-19.</p> more like this
star this property answering member printed Lord Bethell more like this
star this property question first answered
less than 2020-04-02T15:23:39.89Zmore like thismore than 2020-04-02T15:23:39.89Z
star this property answering member
4708
star this property label Biography information for Lord Bethell more like this
star this property tabling member
738
unstar this property label Biography information for Lord Alton of Liverpool more like this
1187333
star this property registered interest false more like this
star this property date less than 2020-03-23more like thismore than 2020-03-23
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care remove filter
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Coronavirus: Drugs more like this
unstar this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government, following their decision to ban the parallel export of drugs used to treat malaria and HIV, whether UK stocks of such medicines are being trialled for use on patients with COVID-19; and if so, what (1) clinical evidence has been gathered, and (2) conclusions have been reached, about the efficacy of such treatment. more like this
star this property tabling member printed
Lord Alton of Liverpool more like this
star this property uin HL2795 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
unstar this property date of answer less than 2020-04-02more like thismore than 2020-04-02
unstar this property answer text <p>United Kingdom stocks of medicines to treat malaria and HIV are being trialled for use on patients with COVID-19.</p><p>There are suggestions in the Chinese and French literature that both lopinavir/ritonavir and chloroquine/hydroxychloroquine may be beneficial. However, these data are not conclusive, because the studies done are too small, thus the findings, whilst promising, may ultimately be wrong.</p><p>The UK will evaluate both these treatments in two large randomised trials, one of which is already underway and the other of which is expected to begin recruitment next week.</p> more like this
star this property answering member printed Lord Bethell more like this
star this property question first answered
less than 2020-04-02T15:31:42.15Zmore like thismore than 2020-04-02T15:31:42.15Z
star this property answering member
4708
star this property label Biography information for Lord Bethell more like this
star this property tabling member
738
unstar this property label Biography information for Lord Alton of Liverpool more like this